Acylcarnitines in fibroblasts of patients with long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency and other fatty acid oxidation disorders
- 1 February 2000
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 23 (1) , 27-44
- https://doi.org/10.1023/a:1005694712583
Abstract
Mitochondrial fatty acid oxidation disorders cause hypoglycaemia, hepatic dysfunction, myopathy, cardiomyopathy and encephalopathy. Despite their recognition for more than 15 years, diagnosis and treatment remain difficult. To help design rational diagnostic and therapeutic strategies, we studied the pathophysiology of accumulating metabolites in a whole‐cell system. Acylcarnitines were quantified in cells and media of cultured fibroblasts after incubation with L‐carnitine and fatty acids. Following incubation with palmitate, long‐chain 3‐hydroxyacyl‐CoA dehydrogenase (LCHAD)‐deficient fibroblasts compared with controls showed elevation of hydroxypalmitoyl‐ and palmitoylcarnitine and reduction of C10‐ and shorter acylcarnitines, and following incubation with linoleate an increase in C14:2‐, C18:2‐ and hydroxy‐C18:2‐acylcarnitines and reduction in C10:1‐acylcarnitines. Hydroxyacylcarnitines remained more intracellular compared to corresponding saturated acylcarnitines. Incubation with decanoate and octanoate showed absence of hydroxylated acylcarnitines and correction of secondary metabolic disturbances, suggesting that optimal treatment should include medium‐chain triglycerides of these chain lengths. Fibroblasts of patients with other fatty acid oxidation disorders showed distinct elevations of disease‐specific acylcarnitines. This acylcarnitine analysis allows the diagnosis of LCHAD deficiency and its differentiation from other fatty acid oxidation disorders, which can pose difficulties in vivo. The strategy has allowed in‐depth analysis with different substrates, providing suggestions for the rational design of treatment trials.Keywords
This publication has 32 references indexed in Scilit:
- Long-chain 3-hydroxyacyl–coenzyme A dehydrogenase deficiency with the G1528C mutation: Clinical presentation of thirteen patientsThe Journal of Pediatrics, 1997
- Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene.Journal of Clinical Investigation, 1996
- The clinical spectrum of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiencyPediatric Neurology, 1996
- Human liver long-chain 3-hydroxyacyl-coenzyme a dehydrogenase is a multifunctional membrane-bound beta-oxidation enzyme of mitochondriaBiochemical and Biophysical Research Communications, 1992
- 3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatmentEuropean Journal of Pediatrics, 1991
- 3-hydroxydicarboxylic aciduria—a fatty acid oxidation defect with severe prognosisThe Journal of Pediatrics, 1990
- The existence of an inner-membrane-bound, long acyl-chain-specific 3-hydroxyacyl-CoA dehydrogenase in mammalian mitochondriaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Propionylcarnitine physiological variations in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1968